Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Reexamination Certificate
2006-05-09
2006-05-09
Epps-Ford, Janet L. (Department: 1633)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
C536S023100, C536S023500, C435S069100, C435S320100
Reexamination Certificate
active
07041497
ABSTRACT:
The present invention is directed to nuclear factor κB (NFκB)-inducing factor polypeptides (NFIF polypeptides) which are capable of inducing NFκB. The present invention includes within its scope NFIF polypeptides, including NFIF-14b and NFIF-7a, DNA, including cDNA, encoding these polypeptides, and expression vectors capable of expressing NFIF polypeptides. Also included are methods and compositions for increasing NFκB induction in a patient, methods and compositions for lowering NFκB induction in a patient, methods for inhibiting inflammation, and methods for manufacture of a medicament intended for the treatment and/or prevention of an NFκB-regulated inflammatory response. In addition, methods for determining whether a test compound inhibits or enhances the activity of NFIF polypeptides are provided.
REFERENCES:
patent: 6132964 (2000-10-01), Bandman et al.
patent: 6518029 (2003-02-01), Bandman et al.
patent: WO99/58675 (1999-11-01), None
patent: WO01/31030 (2001-05-01), None
patent: WO01/53312 (2001-07-01), None
patent: WO01/77389 (2001-10-01), None
patent: WO01/94629 (2001-12-01), None
Sugano et al. Online EMBL Database; “Homo sapienscDNA FLJ20177, Clone COL09966, highly similar to Y08136 H,” Accession No. AK000184, (Feb. 22, 2000).
Chatterjee,Arterioscler. Thromb. Vasc. Biol.18:1523-1533 (1998).
Dias Neto et al.,Proc. Natl. Acad. Sci. USA, 97(7) 3491-3496 (2000).
Gius, et al.,Toxicology Letters, 106:93-106 (1999).
Khaled et al.,Clin. Immunol. Immunopathol., 83(3):254-263 (1997).
Lentsch and Ward,Clin. Chem. Lab. Med., 37(3):205-208 (1999).
Levade and Jaffrezou,Biochim. Biophys. Acta1438:1-17 (1999).
Li and Gaynor,Gene Expr., 7(4-6):233-245 (1999).
Mallat et al.,Circulation, 99:348-353 (1999).
Morrissey and Klahr,Seminars in Nephrology, 18(6):603-611 (1998).
Mukhopadhyay et al.,Oncogene, 11(5):999-1003 (1995).
Murakami et al.,Virology, 206:1066-1074 (1995).
Piette et al.,Biol. Chem., 378:1237-1245 (1997).
Schissel et al.,J. Biol. Chem., 271(31):18431-18436 (1996).
Schuchman et al.,J. Biol. Chem.266(13):8531-8539 (1991).
Sugano et al., Online EMBL Database; “Homo sapienscDNA FLJ20177 fis, clone COL09966, highly similar to Y08136 H”, Accession No.: AK000184, (Feb. 22, 2000).
Tabas et al.,J. Biol. Chem.268(27): 20419-20432 (1993).
Visconti et al.,Oncogene, 15(16) 1987-1994 (1997).
Denefle Patrice
Haws Thomas
Kaplow June
Rosier Marie
Aventis Pharmaceuticals Products Inc.
Epps-Ford Janet L.
Synnestvedt & Lechner LLP
LandOfFree
Nuclear factor κB inducing factor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nuclear factor κB inducing factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nuclear factor κB inducing factor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3567458